85 related articles for article (PubMed ID: 16162748)
41. An evaluation of chest X-ray screening for lung cancer in gunma prefecture, Japan: a population-based case-control study.
Nakayama T; Baba T; Suzuki T; Sagawa M; Kaneko M
Eur J Cancer; 2002 Jul; 38(10):1380-7. PubMed ID: 12091070
[TBL] [Abstract][Full Text] [Related]
42. Association of body mass index with chromosome damage levels and lung cancer risk among males.
Li X; Bai Y; Wang S; Nyamathira SM; Zhang X; Zhang W; Wang T; Deng Q; He M; Zhang X; Wu T; Guo H
Sci Rep; 2015 Mar; 5():9458. PubMed ID: 25820198
[TBL] [Abstract][Full Text] [Related]
43. Body mass index and risk of lung cancer: Systematic review and dose-response meta-analysis.
Duan P; Hu C; Quan C; Yi X; Zhou W; Yuan M; Yu T; Kourouma A; Yang K
Sci Rep; 2015 Nov; 5():16938. PubMed ID: 26582414
[TBL] [Abstract][Full Text] [Related]
44. The Inverse Association of Body Mass Index with Lung Cancer: Exploring Residual Confounding, Metabolic Aberrations and Within-Person Variability in Smoking.
Wood AM; Jonsson H; Nagel G; Häggström C; Manjer J; Ulmer H; Engeland A; Zitt E; Jochems SHJ; Ghaderi S; Stattin P; Bjørge T; Stocks T
Cancer Epidemiol Biomarkers Prev; 2021 Aug; 30(8):1489-1497. PubMed ID: 34162656
[TBL] [Abstract][Full Text] [Related]
45. A case-control study for evaluating lung-cancer screening in Japan. Japanese Lung-Cancer-Screening Research Group.
Sobue T; Suzuki T; Naruke T
Int J Cancer; 1992 Jan; 50(2):230-7. PubMed ID: 1730517
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of a clinic-based screening program for lung cancer with a case-control design in Kanagawa, Japan.
Okamoto N; Suzuki T; Hasegawa H; Gotoh T; Hagiwara S; Sekimoto M; Kaneko M
Lung Cancer; 1999 Aug; 25(2):77-85. PubMed ID: 10470841
[TBL] [Abstract][Full Text] [Related]
47. Smoking and body mass index as risk factors for subtypes of cancer of unknown primary.
Hemminki K; Chen B; Melander O; Manjer J; Hallmans G; Hemminki A
Int J Cancer; 2015 Jan; 136(1):246-7. PubMed ID: 24828693
[No Abstract] [Full Text] [Related]
48. Lower risk of lung cancer after multiple pneumonia diagnoses.
Koshiol J; Rotunno M; Consonni D; Pesatori AC; De Matteis S; Goldstein AM; Chaturvedi AK; Wacholder S; Landi MT; Lubin JH; Caporaso NE
Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):716-21. PubMed ID: 20200440
[TBL] [Abstract][Full Text] [Related]
49. [Theses for the diagnosis of lung cancer].
Barschuk AS; Maximov JA; Prigov AI; Polák J; Podubnyi BK; Rotte KH; Sally-Dobrai G; Stein FM; Widow W; Wilde J
Arch Geschwulstforsch; 1982; 52(1):83-6. PubMed ID: 7082134
[No Abstract] [Full Text] [Related]
50. Lung and fissure shape is associated with age in healthy never-smoking adults aged 20-90 years.
Osanlouy M; Clark AR; Kumar H; King C; Wilsher ML; Milne DG; Whyte K; Hoffman EA; Tawhai MH
Sci Rep; 2020 Sep; 10(1):16135. PubMed ID: 32999328
[TBL] [Abstract][Full Text] [Related]
51. [Disclosure of cancer of the lung in prophylactic examinations by use of large frame fluorography].
Skoblia ES; Mankevich IaP
Vopr Onkol; 1968; 14(9):83-7. PubMed ID: 5686843
[No Abstract] [Full Text] [Related]
52. Lung cancer. Introduction.
Sethi T
Thorax; 2002 Nov; 57(11):992-3. PubMed ID: 12403885
[TBL] [Abstract][Full Text] [Related]
53. Lung cancer outcomes: Are BMI and race clinically relevant?
Braillon A
Lung Cancer; 2021 Apr; 154():224. PubMed ID: 33384206
[No Abstract] [Full Text] [Related]
54. A reply to "Lung cancer outcomes: Are BMI and race clinically relevant?".
Liu G; Brenner H; Chen C; Christiani D; Field JK; Hung R; Jie Z; Le Marchand L; Ryan B; Schabath MB; Schwartz AG; Shete S; Shiraishi K; Tardon A; Teare MD; Yang P; Zhang ZF; Xu W
Lung Cancer; 2021 Apr; 154():225-226. PubMed ID: 33726925
[No Abstract] [Full Text] [Related]
55. Screening for lung cancer.
Petty TL
Ann Intern Med; 1989 Oct; 111(7):620-1. PubMed ID: 2774394
[No Abstract] [Full Text] [Related]
56. ON THE ORIGIN OF LUNG CANCER DEVELOPMENT.
Bolgova LS; Tuganova TN; Alekseenko OI; Ponomarenko AA
Exp Oncol; 2022 May; 44(1):17-22. PubMed ID: 35548970
[TBL] [Abstract][Full Text] [Related]
57. Mass roentgenographic screening as a lung-cancer-control measure.
GUISS LW
Cancer; 1955; 8(2):219-36. PubMed ID: 14352162
[No Abstract] [Full Text] [Related]
58. Body mass index and lung cancer risk: Pooled analysis of 10 prospective cohort studies in Japan.
Kawai S; Lin Y; Tsuge H; Ito H; Matsuo K; Wada K; Nagata C; Narii N; Kitamura T; Utada M; Sakata R; Kimura T; Tamakoshi A; Sugawara Y; Tsuji I; Suzuki S; Sawada N; Tsugane S; Mizoue T; Oze I; Abe SK; Inoue M;
Cancer Sci; 2024 Apr; 115(4):1346-1359. PubMed ID: 38310695
[TBL] [Abstract][Full Text] [Related]
59. Body mass index and incidence of lung cancer in the HUNT study: using observational and Mendelian randomization approaches.
Jiang L; Sun YQ; Brumpton BM; Langhammer A; Chen Y; Mai XM
BMC Cancer; 2022 Nov; 22(1):1152. PubMed ID: 36348315
[TBL] [Abstract][Full Text] [Related]
60. The relationship of cigarette smoking in Japan to lung cancer, COPD, ischemic heart disease and stroke: A systematic review.
Lee PN; Forey BA; Thornton AJ; Coombs KJ
F1000Res; 2018; 7():204. PubMed ID: 30800285
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
